Essex Savings Bank Raises Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Essex Savings Bank increased its position in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 12.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,540 shares of the healthcare conglomerate’s stock after acquiring an additional 285 shares during the period. Essex Savings Bank’s holdings in UnitedHealth Group were worth $1,337,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Robbins Farley acquired a new stake in UnitedHealth Group during the 3rd quarter valued at $25,000. Richelieu Gestion SA acquired a new stake in UnitedHealth Group during the 4th quarter valued at $26,000. CGC Financial Services LLC grew its holdings in UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 50 shares during the last quarter. NewSquare Capital LLC grew its holdings in UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 51 shares during the last quarter. Finally, LFA Lugano Financial Advisors SA grew its holdings in UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after buying an additional 40 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

UNH has been the topic of several analyst reports. Cantor Fitzgerald restated an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a report on Friday, January 19th. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. HSBC reaffirmed a “reduce” rating and issued a $480.00 target price (down from $550.00) on shares of UnitedHealth Group in a research report on Monday, December 18th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $596.00 target price on shares of UnitedHealth Group in a research report on Thursday, February 29th. Finally, Stephens reissued an “overweight” rating and issued a $605.00 price objective on shares of UnitedHealth Group in a research report on Thursday, February 8th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $579.33.

Check Out Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Stock Down 0.8 %

NYSE:UNH traded down $3.97 during mid-day trading on Monday, reaching $490.73. The stock had a trading volume of 836,838 shares, compared to its average volume of 4,043,371. The company has a market capitalization of $452.42 billion, a price-to-earnings ratio of 20.54, a price-to-earnings-growth ratio of 1.35 and a beta of 0.54. UnitedHealth Group Incorporated has a 1-year low of $445.68 and a 1-year high of $554.70. The stock’s 50 day simple moving average is $502.51 and its two-hundred day simple moving average is $519.09. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. The business had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The company’s revenue for the quarter was up 14.1% compared to the same quarter last year. During the same period last year, the firm earned $5.34 earnings per share. Equities analysts anticipate that UnitedHealth Group Incorporated will post 27.82 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.53%. UnitedHealth Group’s payout ratio is currently 31.54%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.